Robert I. Taber
Keine laufenden Positionen mehr
Profil
Robert I.
Taber is the founder.
In 1998, he founded Message Pharmaceuticals, Inc. as a Director.
He also held former positions as Director-Biological Research at Schering Corp.
in 1982, Director at Palatin Technologies, Inc. from 2001 to 2011, Senior Vice President-Research & Development at Lundbeck Research USA, Inc. from 1994 to 1998, and Vice President-Extramural Research & Development at DuPont Merck Pharmaceutical Co. He earned a doctorate degree from the Medical College of Virginia.
Ehemalige bekannte Positionen von Robert I. Taber
Unternehmen | Position | Ende |
---|---|---|
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Gründer | 10.10.2008 |
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
Schering Corp.
Schering Corp. Pharmaceuticals: MajorHealth Technology Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1982 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Technik-/Wissenschafts-/F&E-Leiter | - |
PALATIN TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert I. Taber
Medical College of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PALATIN TECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Health Technology |
Schering Corp.
Schering Corp. Pharmaceuticals: MajorHealth Technology Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY. | Health Technology |